Skip to content

In the BioHarmony Drug Report Database

Dexrazoxane

Totect, Zinecard, Savene (dexrazoxane) is a small molecule pharmaceutical. Dexrazoxane was first approved as Totect on 1995-05-26. It is used to treat breast neoplasms in the USA. It has been approved in Europe to treat extravasation of diagnostic and therapeutic materials.
Trade Name Savene
Common Name Dexrazoxane
Indication breast neoplasms, extravasation of diagnostic and therapeutic materials
Drug Class Alpha-adrenoceptor antagonists (benzodioxane derivatives)
Dexrazoxane
Get full access now